Startseite Frontmatter
Kapitel Öffentlich zugänglich

Frontmatter

Veröffentlichen auch Sie bei De Gruyter Brill
© 2024 Walter de Gruyter GmbH, Berlin/Boston

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Kapitel in diesem Buch

  1. Frontmatter I
  2. Contents V
  3. 1 Introduction to computer simulations in drug delivery: current strategies and future prospects 1
  4. 2 The role of multiscale approaches for the rational design of nanoparticulate drug delivery system: recent advances 19
  5. 3 The utilization of descriptors in convoluted Lipinski’s rule of five 39
  6. 4 Computer-aided pharmacokinetic functions for extravascular route for oral drug delivery system 71
  7. 5 Computational approaches to the prediction of the blood–brain distribution and design of targeted drugs 87
  8. 6 Computational methods in the pragmatic development of nanoemulsions, polymeric micelles, and dendrimers for drug delivery 113
  9. 7 Virtual screening of mucoadhesive polymers for the development of efficient drug delivery system: current approaches 127
  10. 8 QbD and artificial intelligence in nanoparticulate drug delivery systems: recent advances 163
  11. 9 Nanotoxicity prediction in nanotechnology-driven drugs using QSPR modeling 183
  12. 10 Molecular simulations strategies for designing 2D nanomaterials for drug delivery applications 221
  13. 11 Applications and molecular simulation strategies for excipient–excipient compatibility 247
  14. 12 Application of simulation system for selection of nanocarrier for biopharmaceutically challenging pharmaceuticals 269
  15. 13 Applications and challenges in molecular dynamic simulations in polymeric nanoparticle drug delivery systems 307
  16. 14 Role of principal component analysis in drug formulation and delivery 331
  17. 15 Computational approaches for predicting drug solubility and permeability in pharmaceutical formulation 347
  18. 16 Molecular simulations and process modeling of tableting technology: recent advances and future insights 369
  19. 17 Molecular simulation-based technology for antibody–drug conjugates for tumor targeting: current scenario and future insights 383
  20. Index 437
Heruntergeladen am 19.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/9783111208671-fm/html
Button zum nach oben scrollen